Loading chat...

OH SB119

Bill

Status

Enrolled

12/6/2018

Primary Sponsor

Robert Hackett

Click for details

Origin

Senate

132nd General Assembly (2017-2018)

AI Summary

Substitute Senate Bill 119 Summary

  • Allows pharmacists to dispense naltrexone without a prescription under specific conditions when the patient's original prescription has expired and cannot be refilled, limiting oral forms to a five-day supply and permitting pharmacist administration of injectable forms.

  • Establishes liability protections for persons administering injectable naltrexone, employers, and facilities if conditions are met including lack of negligence or intentional misconduct and proper authorization from employer or facility.

  • Requires prescribers initiating medication-assisted treatment to inform patients orally and in writing about all FDA-approved drugs for this treatment and refer non-qualifying practitioners to appropriate providers for buprenorphine or methadone treatment.

  • Expands drug database monitoring to include naltrexone alongside controlled substances and medical marijuana, requiring prescribers to submit information on naltrexone dispensing to the state board of pharmacy.

  • Creates mandatory monthly reporting to the Department of Health regarding naloxone administration by emergency medical services and firefighters, with information compiled by county and forwarded to boards of alcohol, drug addiction, and mental health services.

Legislative Description

Address opioid prescribing and addiction treatment

Health and Human Services : Health Care

Last Action

Motion to reconsider

12/12/2018

Committee Referrals

Health11/13/2018
Health, Human Services and Medicaid4/26/2017

Full Bill Text

No bill text available